Journal article

Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer's disease: Phase 3 study

Osama Sabri, Marwan N Sabbagh, John Seibyl, Henryk Barthel, Hiroyasu Akatsu, Yasuomi Ouchi, Kohei Senda, Shigeo Murayama, Kenji Ishii, Masaki Takao, Thomas G Beach, Christopher C Rowe, James B Leverenz, Bernardino Ghetti, James W Ironside, Ana M Catafau, Andrew W Stephens, Andre Mueller, Norman Koglin, Anja Hoffmann Show all

Alzheimer's & Dementia | ELSEVIER SCIENCE INC | Published : 2015


Funding Acknowledgements

Medical writing support was provided by Dan Booth (Bioscript Medical, London, UK) and funded by Piramal Imaging S.A. Additional statistical analysis was carried out by Santi Bullich (Piramal Imaging GmbH).The trial was funded by Bayer Pharma AG, Berlin (Germany), and Piramal Imaging S.A., Matran (Switzerland). Bayer Pharma AG was involved in the design of the study; Bayer Pharma AG and Piramal Imaging SA were involved in the conduct of the study; collection, management, analysis, and interpretation of the data; and in the preparation, review, and approval of the manuscript.